318 results
Page 9 of 16
6-K
EX-99.1
9byf78mwylzp
16 Mar 12
Live Filing
12:00am
6-K
EX-99.1
p3eeu1defbv
8 Mar 12
Teva Receives FDA Approval for ProAirĀ® HFA (albuterol sulfate) with Dose Counter
12:00am
6-K
EX-99.1
wxtpswm5zh
5 Mar 12
Late Stage Data Demonstrated Long-Term Nasal Symptom Relief and Improvement in Quality of Life
12:00am
6-K
EX-99.1
af996q1x
3 Jan 12
Live Filing
12:00am
6-K
EX-1.3
9a1m1b701pwo xxm6
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-1.2
4abojqz7 7a8chn
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-1.1
yoo1ncj jkvv
10 Nov 11
Current report (foreign)
12:00am
424B5
i3rgv
8 Nov 11
Prospectus supplement for primary offering
12:00am
424B5
xq89an7h9580phmi33kg
7 Nov 11
Prospectus supplement for primary offering
12:00am
6-K
m8was84
2 Nov 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
EX-2.1
imlk3fm
2 Nov 11
Current report (foreign)
12:00am
6-K
EX-2.2
204k1fbe
2 Nov 11
Current report (foreign)
12:00am
6-K
vekfa
19 Oct 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
cwmmh u3nq7b3tql
14 Oct 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
z9kmp 1dgf7cnaj
13 Sep 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
ogozm26ap
8 Aug 11
Teva Receives Fda Acceptance of Its New Drug Application for BDP Nasal Hfa for the Treatment of Allergic Rhinitis
12:00am
6-K
yd6kzxs v4rp091did
2 Aug 11
Results of Phase III Bravo Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment
12:00am
6-K
EX-2.2
ieiitgwxg
28 Jul 11
Current report (foreign)
12:00am
6-K
EX-2.1
98viywjeb4y11k
28 Jul 11
Current report (foreign)
12:00am